Cryotherapy is emerging as a promising strategy to prevent chemotherapy-induced peripheral neuropathy, but adoption in clinical practice remains limited.

EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained ...

Learn the essential early warning signs of leukemia that are often dismissed as everyday ailments but could be indicators of ...

For patients with relapsed/refractory chronic lymphocytic leukemia, extended treatment with Imbruvica and Venclexta was found ...

A cancer patient, with three young kids, touts a 'sci-fi' blood cancer treatment advanced by Vanderbilt and oncologist Dr. Olalekan Oluwole.

This cancer-patient dad of three young kids is grateful for a "sci-fi" blood treatment advanced by Vanderbilt and oncologist Dr. Olalekan Oluwole.

While colorectal cancer cases among older adults have steadily dropped, they've increased among those 50 and younger.

Colon cancer was once primarily a diagnosis for older adults, but the statistics are changing. In recent years, cases have been rising among people younger than 50, which is why the American Cancer ...

Dr. Alan Tan explores circulating tumor DNA, its role in clinical trials and its potential impact on patients with renal cell ...

Frequent blood donors may experience subtle genetic changes that could lower their risk of developing blood cancers, ...

Recent data shows larger inequalities for cancer mortality than cancer incidence in Black Americans compared with White Americans.

A study, published in Cancer Cell, shows that high-grade glioma tumor cells harboring DNA alterations in the gene PDGFRA responded to the drug avapritinib, which is already approved by the United ...